EA201991866A1 - Комбинированная терапия - Google Patents

Комбинированная терапия

Info

Publication number
EA201991866A1
EA201991866A1 EA201991866A EA201991866A EA201991866A1 EA 201991866 A1 EA201991866 A1 EA 201991866A1 EA 201991866 A EA201991866 A EA 201991866A EA 201991866 A EA201991866 A EA 201991866A EA 201991866 A1 EA201991866 A1 EA 201991866A1
Authority
EA
Eurasian Patent Office
Prior art keywords
combined therapy
diseases
treatment
combination
therapy
Prior art date
Application number
EA201991866A
Other languages
English (en)
Inventor
Бенуа Ноэль
Роберт Вальчак
Кароль Беланже
Original Assignee
Женфит
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Женфит filed Critical Женфит
Priority claimed from PCT/EP2018/054305 external-priority patent/WO2018153933A1/en
Publication of EA201991866A1 publication Critical patent/EA201991866A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)

Abstract

Настоящее изобретение относится к комбинации активных ингредиентов для применения в лечении заболеваний.
EA201991866A 2017-04-05 2018-02-21 Комбинированная терапия EA201991866A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17165131 2017-04-05
PCT/EP2018/054305 WO2018153933A1 (en) 2017-02-21 2018-02-21 Combination of a ppar agonist with a fxr agonist

Publications (1)

Publication Number Publication Date
EA201991866A1 true EA201991866A1 (ru) 2020-01-30

Family

ID=58489658

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991866A EA201991866A1 (ru) 2017-04-05 2018-02-21 Комбинированная терапия

Country Status (1)

Country Link
EA (1) EA201991866A1 (ru)

Similar Documents

Publication Publication Date Title
EA201790273A1 (ru) Флагеллиновые композиции и их применение
PH12016501139B1 (en) Bicyclic heterocycle compounds and their uses in therapy
MX2020001513A (es) Agentes de union a clec9a y su uso.
EA201991484A1 (ru) Лекарственные формы энзалутамида
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
EA202092456A3 (ru) Комбинированная терапия, включающая ингибитор mdm2 и один или более дополнительных фармацевтически активных агентов, для лечения различных видов рака
EA201691481A1 (ru) ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ
EA201991997A1 (ru) Комбинированная терапия
CO2019007205A2 (es) Usos terapéuticos de un polvo de insectos
ZA201906100B (en) Combination of a ppar agonist with a fxr agonist
MX2017005861A (es) Metodos para el control transcripcional objetivo en regiones del super mejorador.
EA201690039A1 (ru) Ингибиторы rorc2 и способы их применения
PH12018502161A1 (en) Methods of treatment for cholestatic and fibrotic diseases
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
EA201792560A1 (ru) Наночастицы для применения в качестве терапевтической вакцины
EA202090266A1 (ru) Ингибиторы mpo для применения в медицине
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
EA201992389A1 (ru) Замещенные n-арилэтил-2-аминохинолин-4-карбоксамиды и их применение
MX2018006631A (es) Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas.
EA201790020A1 (ru) Соединения, фармацевтические композиции и их применение при лечении нейродегенеративных заболеваний
EA201991866A1 (ru) Комбинированная терапия
MX2018015240A (es) Composiciones que comprenden timolol y su uso en el tratamiento de rosacea mediante administracion topica.
PH12017501693A1 (en) Compositions for the treatment of kidney and/or liver diseases
EA201592012A1 (ru) Применение флагеллина для улучшенной химиотерапии
TR201716203A1 (tr) Yeni umeklidinyum formülasyonları.